A leading developer of novel cancer therapeutics was experiencing persistent manufacturing process issues. Our engineers were able to diagnose and solve two problems.
Effect of difelikefalin, a selective kappa opioid receptor agonist, on respiratory depression: A randomized, double-blind, placebo-controlled trial
Dr. Beatrice Setnik, Chief Scientific Officer at Altasciences, contributes to the results and findings from a central nervous system (CNS) study.
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2-4 mg for weight management
Scientific article exploring the results and analysis of a randomized, controlled Phase IB trial conducted by Altasciences and Novo Nordisk A/S published on The Lancet.